GVS
870976
Hangzhou CNCR-IT
300250
Shanghai Newtouch Software
688590
4
Ucap Cloud Information Technology Co.,Ltd
688228
5
Yangtze Optical Electronic
688143
US Stock MarketDetailed Quotes
STOK Stoke Therapeutics
- 10.665
- +0.065+0.61%
Trading Jan 24 12:56 ET
564.89MMarket Cap-5.13P/E (TTM)
10.850High10.480Low120.73KVolume10.590Open10.600Pre Close1.29MTurnover0.33%Turnover RatioLossP/E (Static)52.97MShares17.58052wk High2.43P/B391.61MFloat Cap4.09052wk Low--Dividend TTM36.72MShs Float71.580Historical High--Div YieldTTM3.49%Amplitude3.350Historical Low10.651Avg Price1Lot Size
Trending Stocks
Discussing
January rate meeting coming! Fed's pause in rate cuts a foregone conclusion?
🎙️Discussion 1. Will the Fed press the "pause button" on rate cuts as expected? 2. Do you think President Trump's political actions will ch
In One Chart
Jan 15 22:05
Here's the Breakdown for December CPI, in One Chart
Stoke Therapeutics Stock Forum
Stoke Therapeutics Receives FDA Breakthrough Therapy Designation for Zorevunersen for the Treatment of Dravet Syndrome
In the rapidly evolving world of biotechnology, companies like Stoke Therapeutics are pioneering groundbreaking treatments that could potentially change the lives of patients with severe diseases. The recent buzz surrounding Stoke Therapeutics, particularly their work on an anti-epilepsy drug, STK-001, underscores the transformative potential of RNA-based therapies in addres...
No comment yet